News Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Continue Reading Previous Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial ResistanceNext XORTX Announces Participation at Upcoming Investor Conferences Related Stories News TMX Group Thanksgiving Holiday Market Closures News TIPAK Marks Path to Leadership in Packaging Solutions Following Listing on SET News Chervon Names Daniel L. Abbott Director of Sales – Western U.S.A. News Chervon Names Peter J. Carlson Director of Sales for Strategic Accounts News Chervon Appoints Neil Harrison to the Position of VP Sales, Marketing and MD for Chervon Canada News Pelican Announces Appointment of Nino Di Teodoro to Its Board of Directors